Dynavax Announces First Quarter 2021 Financial Results

Go back to Dynavax Announces First Quarter 2021 Financial Results

Dynavax (DVAX) Tops Q1 EPS by 3c

May 6, 2021 5:30 PM EDT

Dynavax (NASDAQ: DVAX) reported Q1 EPS of $0.01, $0.03 better than the analyst estimate of ($0.02). Revenue for the quarter came in at $83.3 million versus the consensus estimate of $59.11 million.

"The first quarter of 2021 continued to build on our successful execution in 2020. With the combined strength of opportunities from HEPLISAV-B and CpG 1018, we believe... More